Abrdn Life Sciences Investors Fund Q4 2025 Commentary
Source: SeekingAlpha
2026-02-25 21:20:00 ET
The equity portion of the Fund rose (gross of fees) but underperformed its benchmark, the NASDAQ Biotechnology Index. 1...
Read the full article on Seeking Alpha
For further details see:
Abrdn Life Sciences Investors Fund Q4 2025 Commentary
TeklaLife Sciences Investors
NASDAQ: HQL
HQL Trading
-1.28% G/L:
$16.435 Last:
24,787 Volume:
$16.65 Open:
HQL Latest News
February 10, 2026 04:17:00 pm
Certain Aberdeen Investments U.S. Closed-End Funds Declare Distribution Dates and Amounts
February 02, 2026 05:00:50 am
This Top AI Trade for 2026 Pays a Huge 11.6% Dividend (It's Not a Tech Stock)
June 30, 2025 04:17:00 pm
ABERDEEN INVESTMENTS U.S. CLOSED-END FUNDS ANNOUNCE DISTRIBUTION PAYMENT DETAILS
